Ondrej H.

Ondrej H. is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as Business Manager for the Czech Republic, Hungary, Romania, and Slovakia at Recordati Rare Diseases since March 2023. Previously held the role of Business Director at EUSA Pharma, overseeing P&L responsibilities for the same regions from November 2020 to February 2023. Prior experience includes leading CSL Behring as General Manager, where Ondrej built the business from inception to achieving $30 million in sales. A background with GSK spans various leadership positions, including General Manager, Governmental Affairs Director, and Marketing Director, contributing to strategic planning and market execution. Ondrej's academic achievements include a Master's degree in Human Genetics and Biology from Charles University.